share_log

Arcutis Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

SEC announcement ·  Feb 27 16:37
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc., a biopharmaceutical company based in California, filed a Registration Statement with the U.S. Securities and Exchange Commission (SEC) on February 27, 2024. The filing, under Form S-8, is for the registration of an additional 4,839,367 shares of common stock. These shares are to be issued under the company's 2020 Equity Incentive Plan and 2020 Employee Stock Purchase Plan, which have been previously effective through earlier registration statements. The additional shares are a result of automatic annual increase provisions in the plans. The company, incorporated in Delaware and led by President and CEO Todd Franklin Watanabe, is classified as a non-accelerated filer and a smaller reporting company. The filing includes references to earlier filed documents and exhibits, such as the Restated Certificate of Incorporation, Restated Bylaws, and forms of Common Stock Certificate, as well as legal opinions and consents from Latham & Watkins LLP and the company's independent registered public accounting firm.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company based in California, filed a Registration Statement with the U.S. Securities and Exchange Commission (SEC) on February 27, 2024. The filing, under Form S-8, is for the registration of an additional 4,839,367 shares of common stock. These shares are to be issued under the company's 2020 Equity Incentive Plan and 2020 Employee Stock Purchase Plan, which have been previously effective through earlier registration statements. The additional shares are a result of automatic annual increase provisions in the plans. The company, incorporated in Delaware and led by President and CEO Todd Franklin Watanabe, is classified as a non-accelerated filer and a smaller reporting company. The filing includes references to earlier filed documents and exhibits, such as the Restated Certificate of Incorporation, Restated Bylaws, and forms of Common Stock Certificate, as well as legal opinions and consents from Latham & Watkins LLP and the company's independent registered public accounting firm.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more